Below is a summary of the factors that might affect your response to stem cell therapy, and how we at Beike Biotechnology address each factor to ensure that we provide you with the highest efficacy using the safest procedure possible.

• Dose/Number of stem cells: The higher the dose of stem cells – within limits of course – the better the response. At Beike Biotechnology, we administer an optimum dose of around 120-280 Million Cells (depending on the child’s weight) for autism.
• Route/Method of administration: Studies have shown that intrathecal injection (through lumbar puncture directly within the brain’s CSF) provides better response than the traditional intravenous route (which causes stem cells to go to other organs than the brain before reaching the brain). At Beike Biotechnology, we use both intravenous and intrathecal routes concomitantly in order to obtain the maximal efficacy; while ensuring the least possible side effects or toxicity.
• Type of Stem Cells used: As previously mentioned, both umbilical cord-based stem cells, which we use at Beike Biotechnology, and bone marrow stem cells have better-proven efficacy in autism compared to other types of stem cells.
• Timing of stem cell transplantation: Early intervention is crucial for people with different neurodevelopmental disorders – including autism. Therefore, we recommend early intervention during early school years (around 3 to 7 years old).
• Follow-up Time: Significant benefits from stem cell therapy begin appearing around three months after stem cell therapy, and most people reach their full potential around 6-12 months after treatment. At Beike Technology, even after discharge, we provide you with a full follow-up program beginning as early as one month and up to one year after transplantation. You have complete access to our professional team even after you leave our center.